Dr. Jennifer Yu-Fe Lin Levy, MD

Dr. Lin Levy practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Lin Levy's NPI, 1568598308, was assigned on February 26, 2007. Dr. Lin Levy graduated from Harvard Medical School in 2003. Dr. Lin Levy holds California license C193459.

Dr. Lin Levy's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Lin Levy's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Lin Levy is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Lin Levy to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin Levy practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lin Levy's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lin Levy is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lin Levy's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Lin Levy treats.

CMS data shows 1,529 Medicare services from Dr. Lin Levy across 12 procedure codes in 2024, for 373 Medicare patients. Medicare paid $76,387 for them.

CMS counts 373 Medicare patients who saw Dr. Lin Levy in 2024. The largest group is 65 to 74, with 188 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin Levy's median patient age at 59, with 59% women.

In 2024, Dr. Lin Levy wrote 671 Medicare Part D claims for 284 patients. 94% of them were for generic drugs. CMS names the drug for 521 of them, across 19 drugs with 11 or more claims each, at $16,202 in total drug cost. In 2023, CMS named 155 claims across 8 drugs.

Dr. Lin Levy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin Levy as offering telehealth. CMS counts 776 procedures of removal of skin lesions by Dr. Lin Levy, more than 91% of the clinicians it reports for that procedure.

CMS Open Payments shows 22 general payments to Dr. Lin Levy from 4 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 84% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $14,059. It also lists 8 research payments totaling $1,570 in 2025, naming 1 clinical trial.

Dr. Lin Levy graduated from Harvard Medical School in 2003.

Dr. Lin Levy is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.